Suchergebnisse - "Lv, Huibin"

PubPharm (10)

1

Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity

enthalten in: Cell reports | 2023

von Yuan, M. | Feng, Z. | Lv, H. | +8

UpdateOf: bioRxiv. 2023 Jun 07;:. - PMID 37333077

2

Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2

enthalten in: Cell reports | 2022

von Yuan, M. | Wang, Y. | Lv, H. | +3

UpdateOf: bioRxiv. 2022 May 18;:. - PMID 35611339

3

A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2

enthalten in: Immunity | 2022

von Wang, Y. | Yuan, M. | Lv, H. | +3

UpdateOf: bioRxiv. 2021 Nov 30;:. - PMID 34873599

4

Phenotypic and genetic characterization of MERS coronaviruses from Africa to understand their zoonotic potential

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Zhou, Z. | Hui, K. | So, R. | +25

5

Kinetics of viral load and antibody response in relation to COVID-19 severity

enthalten in: The Journal of clinical investigation | 2020

von Wang, Y. | Zhang, L. | Sang, L. | +41

CommentIn: J Clin Invest. 2020 Oct 1;130(10):5112-5114. - PMID 32634126

6

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

enthalten in: Science (New York, N.Y.) | 2020

von Arunachalam, P. | Wimmers, F. | Mok, C. | +28

7

COVID-19 vaccines : Knowing the unknown

enthalten in: European journal of immunology | 2020

von Lv, H. | Wu, N. | Mok, C.

8

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections

enthalten in: Cell reports | 2020

von Lv, H. | Wu, N. | Tsang, O. | +16

UpdateOf: bioRxiv. 2020 Mar 17;:. - PMID 32511317

9

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections

enthalten in: Cell reports | 2020

von Lv, H. | Wu, N. | Tsang, O. | +16

10

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

enthalten in: Science (New York, N.Y.) | 2020

von Yuan, M. | Wu, N. | Zhu, X. | +5

1
[1]